
Erlotero 150mg tablet
Salt Composition: Erlotinib
Expiry Date: 01/2028
Inclusive of all taxes
30 Tablets in Strip

Erlotero 150mg tablet
30 Tablets in Strip
Erlotinib
Salt Composition
Erlotinib
Storage
Below 25°C
Expiry Date
01/2028
Marketer
Hetero
Brand
erlotero

Zyceva 100mg Tablet
30 Tablet in Bottle
Erlotinib
Salt Composition
Erlotinib
Storage
Below 25°C
Expiry Date
01/2028
Marketer
zydus cadila
Brand
zyceva
5966.png&w=1920&q=75)
MAGIC DEALS
Buy at $79.49
Apply Promo Code
Available CouponsErlotero 150mg tablet
Inclusive of all taxes
In Stock
Authorized
Global Reach
Verified Logistics
The price displayed is inclusive of applicable taxes. Any additional fee (such as shipping fee, handling and/or platform fee etc.) will be clearly disclosed before you complete your purchase.
About The Product
Non-small cell lung cancer
Description
Erlotero 150mg tablet is a Target therapy based anticancer medication prescribed by the doctor to treat advanced Non Small Cell Lung Cancer (NSCLC) with specific EGFR gene mutation as well as Pancreatic Cancer in combination with other medicine.
Erlotero 150mg tablet contains Erlotinib that blocks cancer cell growth and proliferation via angiogenesis.
Common Side Effects
- Erlotero 150mg tablet is a chemical based anti cancer medication.
- Like any other chemotherapeutic drug, it also has multiple side effects that range from common to extreme.
- Consult your doctor, if symptoms persists for longer period of time or if you experience any of the serious side effects. ● Vomiting ● Nausea ● Fatigue ● Diarrhea ● Decreased Appetite ● Abdominal Pain ● Dry Skin ● Mouth Sores ● Constipation ● Rashes ● Weight Loss ● Headache ● Arthralgia ● Dyspnea ● Pneumonitis ● Vision Related Issues
Dosage And Administration
- The standard recommended starting dosage of Erlotero 150mg tablet is once daily.
- This medicine is taken orally as whole on an empty stomach, without breaking, biting or chewing.
- Consult your doctor for exact dosage that is especially meant for you.
Mechanism Of Action
Erlotero 150mg tablet contains Erlotinib that belongs to the class of tyrosine kinase inhibitor. Erlitinib blocks the abnormal EGFR protein kinase that is responsible for cancer cell growth and proliferation via angiogenesis.
Abnormal EGFR protein blockage inhibits cancer cell growth.
Faqs
Erlotero 150mg tablet cause harm to growing fetus as well as is teratogenic in nature.
Thus, it is not recommended during pregnancy for treatment.
References
• Becker, A., van Wijk, A., Smit, E. F., & Postmus, P.
E. (2010).
Side-effects of long-term administration of erlotinib in patients with non-small cell lung cancer. Journal of Thoracic Oncology, 5(9), 1477-1480. • Tang, P.
A., Tsao, M. S., & Moore, M.
J. (2006).
A review of erlotinib and its clinical use. Expert opinion on pharmacotherapy, 7(2), 177-193. • Abdelgalil, A.
A., Al-Kahtani, H. M., & Al-Jenoobi, F.
I. (2020).
Erlotinib. In Profiles of drug substances, excipients and related methodology (Vol.
45, pp. 93-117).
Academic Press. • Gridelli, C., Bareschino, M. A., Schettino, C., Rossi, A., Maione, P., & Ciardiello, F.
(2007). Erlotinib in non-small cell lung cancer treatment: current status and future development.
The oncologist, 12(7), 840-849.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
.jpeg%3FupdatedAt%3D1763121181831&w=128&q=75)